In Special Issue 9 of 2019 P. Meijer (1) and M.P.M. de Maat (2) (1ECAT Foundation, Voorschoten, The Netherlands. 2Department of Hematology, Erasmus MC, University Medical Center Rotterdam, The Netherlands) described the quality assurance of replacement therapy and future perspectives.
